Appeal No. 2003-0998 Page 5 Application No. 08/676,143 2. Enablement The examiner rejected all of the claims on appeal for nonenablement. The examiner acknowledged that the claims were enabled for synthetic receptors having steroids as templates (or the templates recited in claims 68-71) but held that the claims were not enabled for synthetic receptors having monocyclic aliphatic hydrocarbons, polycyclic aliphatic hydrocarbons, or monocyclic heterocycles as templates. See the Examiner’s Answer, page 4. The examiner apparently concluded that the specification was deficient in teaching those skilled in the art both how to make and how to use the claimed products. With regard to how to make the claimed library, the examiner considered several of the Wands factors and concluded that making the claimed products would have required undue experimentation. See the Examiner’s Answer, pages 5-6. In addition, the examiner concluded that, even assuming “that one could make synthetic receptor libraries, . . . as encompassed by the present claims, the specification fails to provide sufficient guidance regarding a specific, substantial and credible use for a representative sample of such compounds.” Id., pages 6-8. Appellants argue that the specification exemplifies compounds having a monocyclic heterocycle template, as well as compounds having a polycyclic aliphatic hydrocarbon template. Thus, Appellants assert, “[t]he only template that is not exemplified is a monocyclic aliphatic hydrocarbon. . . . Appellants submit that the person of ordinary skill would expect that a genus including monocyclicPage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 NextLast modified: November 3, 2007